In 2018, Waldner et al. [54] noticed that there was a significant increase in ApoD in the plasma of patients with PD (mean 104.15 ± 30.96 ng/mL) as compared with age-matched healthy patients (mean 79.35 ± 26.25 ng/mL). This evidence concerns the gene APOD and Parkinson disease.